Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
B8V4JA
|
|||
| Binder Name |
Furafylline
|
|||
| Synonyms |
3-Furfuryl-1,8-dimethylxanthine; UNII-C2087G0XX3; 3-(furan-2-ylmethyl)-1,8-dimethyl-1H-purine-2,6(3H,7H)-dione; 3-(2-Furanylmethyl)-3,7-dihydro-1,8-dimethyl-1H-purine-2,6-dione; 3-(furan-2-ylmethyl)-1,8-dimethyl-7H-purine-2,6-dione; CHEMBL405845; C2087G0XX3; NCGC00015426-04; DSSTox_CID_25153; DSSTox_RID_80707; DSSTox_GSID_45153; Furafylline [INN]; Furafilina [Spanish]; Furafyllinum [Latin]; Furafilina; Furafyllinum; Furafilina;Furafyllinum; Lopac-F-124; Lopac0_000538; SCHEMBL191214; DTXSID2045153; CTK5E7657; Furafylline, >=98% (HPLC); HMS2089A08; HMS3261L17; BCP20952; ZINC9227032; Tox21 110143; Tox21_110143; Tox21_500538; BDBM50236897; MFCD00153799; AKOS027380039; Tox21_110143_1; CCG-204628; LP00538; SDCCGSBI-0050521.P002; NCGC00015426-01; NCGC00015426-02; NCGC00015426-03; NCGC00015426-05; NCGC00015426-06; NCGC00015426-07; NCGC00015426-08; NCGC00015426-09; NCGC00015426-14; NCGC00093927-01; NCGC00093927-02; NCGC00093927-03; NCGC00093927-04; NCGC00261223-01; AC-32562; BS-17557; HY-107204; CS-0027630; EU-0100538; F-124; A17085; BIM-0050521.0001; AB01275435-01; SR-01000076233; Q5509469; SR-01000076233-1; 3-(2-furfuryl)-1,8-dimethyl-7H-purine-2,6-quinone; 3-(2-furylmethyl)-1,8-dimethyl-7H-purine-2,6-dione; 3-(uran-2-ylmethyl)-1,8-dimethyl-7H-purine-2,6-dione; 3-(furan-2-ylmethyl)-1,8-dimethyl-3,7-dihydro-1H-purine-2,6-dione
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H12N4O3
|
|||
| Canonical SMILES |
CC1=NC2=C(N1)C(=O)N(C(=O)N2CC3=CC=CO3)C
|
|||
| InChI |
1S/C12H12N4O3/c1-7-13-9-10(14-7)16(6-8-4-3-5-19-8)12(18)15(2)11(9)17/h3-5H,6H2,1-2H3,(H,13,14)
|
|||
| InChIKey |
KGQZGCIVHYLPBH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:165840
|
|||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.